相关实验视频
Updated: Jan 13, 2026

07:06
Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
15.9K
2014-2024年期间消除脊髓灰质炎进展的障碍:有效应对当前的挑战
Steven G F Wassilak1, Abdinoor Mohamed2, John Paul Bigouette2
1Independent Researcher, Atlanta, GA 30307, USA.
Vaccines
|October 28, 2025
概括
全球消除脊髓灰质炎的努力面临重大障碍,包括资金和政治意愿的减少,威胁到进展. 迫切需要采取行动,以克服挑战,实现无脊髓灰质炎的世界.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 传染病控制和控制传染病
背景情况:
- 全球脊髓灰质炎根除倡议 (GPEI) 的目标是到2000年根除脊髓灰质炎,但挑战仍然存在.
- 野生脊髓灰质炎病毒仍然在阿富汗和巴基斯坦流行,目前正在发生疫苗衍生的2型脊髓灰质炎病毒爆发.
研究的目的:
- 详细说明自2014年以来脊髓灰质炎根除进展的障碍.
- 为了审查GPEI必须缓解的挑战,以便成功地消除全球脊髓灰质炎.
主要方法:
- 对消除小儿麻症进展的障碍进行审查.
- 分析GPEI面临的挑战.
主要成果:
- 在阿富汗和巴基斯坦持续的野生脊髓灰质炎病毒传播.
- 挑战包括失去了紧迫性,免疫覆盖率下降,疫情应对质量下降.
- 安全问题和GPEI资金减少构成严重威胁.
结论:
- 通过紧急有效地缓解已识别的挑战,可以实现根除.
- 加强政治意愿,常规免疫接种和疫情应对措施至关重要.
- 解决资金短缺至关重要,以防止进展逆转.
相关概念视频
Vaccinations
51.2K
Overview
51.2K
Steps in Outbreak Investigation
485
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
485
International Nursing Organizations II
1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Infection
11.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.8K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928

